{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-065655","form_type":"8-K","ticker":"RXST","cik":"0001111485","company_name":"RxSight, Inc.","filed_at":"2025-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.555014+00:00","generated_at":"2026-05-22T07:01:00.301771+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"RxSight Q1 revenue $37.9M (+28% YoY); LAL volume up 36%","bullets":["Q1 revenue $37.9M (+28% YoY); LAL revenue +37%, LDD revenue +8%.","Net loss $(8.2M) or $(0.20)/share; adjusted net loss $(1.1M) or $(0.03)/share.","27,579 LALs sold (+36% YoY); 73 LDDs; installed base 1,044 (+43% YoY).","Gross margin 74.8% vs 70.1% YoY; cash $229.3M at quarter end.","Reiterated FY2025 guidance: revenue $160-175M, GM 71-73%, OpEx $150-160M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-065655","json":"https://secwatch.observer/filing/0000950170-25-065655.json","markdown":"https://secwatch.observer/filing/0000950170-25-065655.md","text":"https://secwatch.observer/filing/0000950170-25-065655.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1111485/000095017025065655/0000950170-25-065655-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1111485/000095017025065655/rxst-20250507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T07:01:00.301771+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}